in_vitro_activities
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | |||
| in_vitro_activities [2025/11/19 16:37] – renefeyereisen | in_vitro_activities [2025/12/23 17:27] (current) – renefeyereisen | ||
|---|---|---|---|
| Line 14: | Line 14: | ||
| < | < | ||
| - | |||
| - | ===== In vitro activities ===== | ||
| - | |||
| - | key: | ||
| - | P: purified enzyme | ||
| - | E: E.coli expression | ||
| - | B: baculovirus expression | ||
| - | D: Drosophila cell transfection | ||
| - | Y: yeast expression | ||
| - | O: other expression system. | ||
| - | Negative results (i.e. no metabolism detected) are listed when available. | ||
| |^CYP^species^in vitro activity ^reference^ | |^CYP^species^in vitro activity ^reference^ | ||
| ^**CYP2 clan**|||| | ^**CYP2 clan**|||| | ||
| ^CYP2L1| Panulirus argus (spiny lobster)|O: | ^CYP2L1| Panulirus argus (spiny lobster)|O: | ||
| - | ^[[cyp15|CYP15A1]]|Diploptera punctata|P: methyl farnesoate to JH III|Helvig et al. 2004a| | + | ^[[cyp15|CYP15A1]]|Diploptera punctata|P: methyl farnesoate to R-JH III|Helvig et al. 2004a| |
| ^[[cyp15|CYP15A1]]|Diploptera punctata|D: farnesoic acid to JH III |Jia et al. 2024| | ^[[cyp15|CYP15A1]]|Diploptera punctata|D: farnesoic acid to JH III |Jia et al. 2024| | ||
| ^CYP15A1|Tribolium castaneum|O: | ^CYP15A1|Tribolium castaneum|O: | ||
| ^CYP15A1|Apis mellifera|P: | ^CYP15A1|Apis mellifera|P: | ||
| + | ^CYP15A1|Scleroderma guani (parasitic wasp) |P:methyl farnesoate to S-JH III|Ouyang et al., 2025| | ||
| ^CYP15C1|Bombyx mori|D: farnesoic acid 18x> methyl farnesoate|Daimon et al., 2012| | ^CYP15C1|Bombyx mori|D: farnesoic acid 18x> methyl farnesoate|Daimon et al., 2012| | ||
| ^CYP18A1|Drosophila melanogaster|D: | ^CYP18A1|Drosophila melanogaster|D: | ||
| Line 67: | Line 57: | ||
| ^CYP3002B2|Varroa destructor|E: | ^CYP3002B2|Varroa destructor|E: | ||
| ^[[cnglc|CYP3201B1]]|Chamberlinius hualieniensis|Y: | ^[[cnglc|CYP3201B1]]|Chamberlinius hualieniensis|Y: | ||
| + | ^[[cnglc|CYP30008A2]]|Chamberlinius hualienensis|Y: | ||
| ^**CYP3 clan**|||| | ^**CYP3 clan**|||| | ||
| ^[[CYP6A1]]|Musca domestica|P: | ^[[CYP6A1]]|Musca domestica|P: | ||
| Line 120: | Line 111: | ||
| ^CYP6M2|Anopheles gambiae|E: pyrethroids, | ^CYP6M2|Anopheles gambiae|E: pyrethroids, | ||
| ^CYP6M7|Anopheles funestus|E: pyrethroids|Riveron et al.,2014| | ^CYP6M7|Anopheles funestus|E: pyrethroids|Riveron et al.,2014| | ||
| + | ^CYP6J5|Anopheles gambiae|E: | ||
| ^CYP6P2|Anopheles gambiae|E: pyriproxyfen|Yunta et al., 2016| | ^CYP6P2|Anopheles gambiae|E: pyriproxyfen|Yunta et al., 2016| | ||
| ^CYP6P2|Anopheles gambiae|E: permethrin, etofenprox, deltamethrin; | ^CYP6P2|Anopheles gambiae|E: permethrin, etofenprox, deltamethrin; | ||
| Line 125: | Line 117: | ||
| ^CYP6P3|Anopheles gambiae|E: chlorfenapyr|Yunta et al., 2023| | ^CYP6P3|Anopheles gambiae|E: chlorfenapyr|Yunta et al., 2023| | ||
| ^CYP6P3 E205D allele|Anopheles gambiae|E: permethrin, a-cypermethrin, | ^CYP6P3 E205D allele|Anopheles gambiae|E: permethrin, a-cypermethrin, | ||
| + | ^CYP6P3|Anopheles gambiae|E: | ||
| ^CYP6P4|Anopheles gambiae|E: permethrin, etofenprox, deltamethrin; | ^CYP6P4|Anopheles gambiae|E: permethrin, etofenprox, deltamethrin; | ||
| ^CYP6P4|Anopheles gambiae|E: pyriproxyfen|Yunta et al., 2019| | ^CYP6P4|Anopheles gambiae|E: pyriproxyfen|Yunta et al., 2019| | ||
| Line 132: | Line 125: | ||
| ^CYP6P5|Anopheles gambiae|E: pyriproxyfen|Yunta et al., 2016| | ^CYP6P5|Anopheles gambiae|E: pyriproxyfen|Yunta et al., 2016| | ||
| ^CYP6P5|Anopheles gambiae|E: permethrin, etofenprox, deltamethrin; | ^CYP6P5|Anopheles gambiae|E: permethrin, etofenprox, deltamethrin; | ||
| + | ^CYP6P3|Anopheles gambiae|E: | ||
| + | ^CYP6P5|Anopheles gambiae|E: | ||
| ^CYP6P5|Anopheles albimanus|E: | ^CYP6P5|Anopheles albimanus|E: | ||
| ^CYP6P7|Anopheles minimus|B: | ^CYP6P7|Anopheles minimus|B: | ||
| Line 151: | Line 146: | ||
| ^CYP6Z2|Anopheles gambiae|E: pyriproxyfen|Yunta et al., 2016| | ^CYP6Z2|Anopheles gambiae|E: pyriproxyfen|Yunta et al., 2016| | ||
| ^CYP6Z2|Anopheles gambiae|B: carbaryl|Chiu et al., 2008| | ^CYP6Z2|Anopheles gambiae|B: carbaryl|Chiu et al., 2008| | ||
| - | ^CYP6Z2|Anopheles gambiae|Y: non-toxic esterase metabolites of pyr.|Chandor-Proust et al. 2013| | + | ^CYP6Z2|Anopheles gambiae|E: non-toxic esterase metabolites of pyr.|Chandor-Proust et al. 2013| |
| - | ^CYP6Z8|Aedes aegypti|Y: non-toxic esterase metabolites of pyr.|Chandor-Proust et al. 2013| | + | ^CYP6Z2|Anopheles gambiae|E: |
| + | ^CYP6Z3|Anopheles gambiae|E: | ||
| + | ^CYP6Z8|Aedes aegypti|Y: non-toxic esterase metabolites of pyr., | ||
| ^CYP6AA1|Anopheles funestus|E: bendiocarb, pyrethroids|Ibrahim et al., 2018| | ^CYP6AA1|Anopheles funestus|E: bendiocarb, pyrethroids|Ibrahim et al., 2018| | ||
| ^CYP6AA3|Anopheles minimus|B: deltamethrin|Boonsuepsakul et al., 2008| | ^CYP6AA3|Anopheles minimus|B: deltamethrin|Boonsuepsakul et al., 2008| | ||
| Line 172: | Line 169: | ||
| ^CYP6AE14|Helicoverpa armigera|Y: P-nitroanisole, | ^CYP6AE14|Helicoverpa armigera|Y: P-nitroanisole, | ||
| ^CYP6AE14|Helicoverpa armigera|B: | ^CYP6AE14|Helicoverpa armigera|B: | ||
| - | ^CYP6AE15|Helicoverpa armigera|B: IMI|Shi et al., 2018| | + | ^CYP6AE15|Helicoverpa armigera|B: IMI|Shi et al., 2018| |
| + | ^CYP6AE15|Helicoverpa armigera|Y: oripavine N-demethylation|Xue et al., 2026 | | ||
| ^CYP6AE16|Helicoverpa armigera|B: IMI, aldrin|Shi et al., 2018| | ^CYP6AE16|Helicoverpa armigera|B: IMI, aldrin|Shi et al., 2018| | ||
| ^CYP6AE17|Helicoverpa armigera|B: EC, BFC, IMI, aldrin|Shi et al., 2018| | ^CYP6AE17|Helicoverpa armigera|B: EC, BFC, IMI, aldrin|Shi et al., 2018| | ||
| Line 216: | Line 214: | ||
| ^CYP6CM1vQ|Bemisia tabaci|E: aldrin|Shi et al., 2018| | ^CYP6CM1vQ|Bemisia tabaci|E: aldrin|Shi et al., 2018| | ||
| ^CYP6CM1vQ|Bemisia tabaci|Y: luciferin substrates, pymetrozine, | ^CYP6CM1vQ|Bemisia tabaci|Y: luciferin substrates, pymetrozine, | ||
| + | ^CYP6CM1vQ|Bemisia tabaci|E: various phenolic compounds as inhibitors of 7-ethoxycoumarin deethylation |Ioannou et al., 2026| | ||
| ^CYP6CM1|Bemisia tabaci|B: | ^CYP6CM1|Bemisia tabaci|B: | ||
| ^CYP6CM1|Bemisia tabaci|E: pyriproxifen, | ^CYP6CM1|Bemisia tabaci|E: pyriproxifen, | ||
| Line 260: | Line 259: | ||
| ^CYP9A3|Helicoverpa armigera |B: | ^CYP9A3|Helicoverpa armigera |B: | ||
| ^CYP9A9|Spodoptera exigua |B: | ^CYP9A9|Spodoptera exigua |B: | ||
| + | ^CYP9A9a (=mutant V40L, | ||
| + | ^CYP9A9b (=wt)|Spodoptera exigua |B: | ||
| ^CYP9A10|Spodoptera exigua |B: | ^CYP9A10|Spodoptera exigua |B: | ||
| ^CYP9A11|Spodoptera exigua |B: | ^CYP9A11|Spodoptera exigua |B: | ||
| Line 369: | Line 370: | ||
| ^CYP321A8|Spodoptera exigua|B: | ^CYP321A8|Spodoptera exigua|B: | ||
| ^CYP321A8|Spodoptera frugiperda|P: | ^CYP321A8|Spodoptera frugiperda|P: | ||
| + | ^CYP321A9|Spodoptera frugiperda|P: | ||
| ^CYP321A19 aka CYP321A16|Spodoptera exigua|B: | ^CYP321A19 aka CYP321A16|Spodoptera exigua|B: | ||
| ^CYP321A19|Spodoptera litura|B: | ^CYP321A19|Spodoptera litura|B: | ||
| Line 405: | Line 407: | ||
| ^CYP4CE1|Nilaparvata lugens|B: nitenpyram, imidacloprid NOT tricin, hesperetin, proquamezine, | ^CYP4CE1|Nilaparvata lugens|B: nitenpyram, imidacloprid NOT tricin, hesperetin, proquamezine, | ||
| ^CYP4CE2|Laodelphax stritellus|P: | ^CYP4CE2|Laodelphax stritellus|P: | ||
| - | ^CYP4FB1|Laodelphax striatellus|B: | + | ^CYP4FB1|Laodelphax striatellus|B: |
| + | ^[[cnglc|CYP4GL4]]|Chamberlinius hualienensis|Y: | ||
| ^CYP325A ?|Anopheles funestus|E: pyrethroids|Wamba et al., 2021| | ^CYP325A ?|Anopheles funestus|E: pyrethroids|Wamba et al., 2021| | ||
| ^CYP340G2|Spodoptera litura|B: | ^CYP340G2|Spodoptera litura|B: | ||
| Line 414: | Line 417: | ||
| ^CYP389C16|Tetranychus cinnabarinus|E: | ^CYP389C16|Tetranychus cinnabarinus|E: | ||
| ^[[cnglc|CYP405A2]]|Zygaena filipendula|Y: | ^[[cnglc|CYP405A2]]|Zygaena filipendula|Y: | ||
| - | ^CYP417A2v2|Laodelphax striatellus|B: | + | ^CYP417A2v2|Laodelphax striatellus|B: |
| + | ^CYP425A1|Nilaparvata lugens|B: etofenprox to 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzoate (ester metabolite) |Zhang et al., 2026| | ||
| ^CYP439A1v3|Laodelphax striatellus|B: | ^CYP439A1v3|Laodelphax striatellus|B: | ||
| ^CYP439A1|Nilaparvata lugens|buprofezin|Zeng et al.2023| | ^CYP439A1|Nilaparvata lugens|buprofezin|Zeng et al.2023| | ||
| Line 448: | Line 452: | ||
| ^CYP339A1|Helicoverpa armigera|B: esfenvalerate|Shi et al. 2022| | ^CYP339A1|Helicoverpa armigera|B: esfenvalerate|Shi et al. 2022| | ||
| ^CYP339A1|Spodoptera litura|B: | ^CYP339A1|Spodoptera litura|B: | ||
| - | ^CYP353D1v2|Laodelphax striatellus|B: | + | ^CYP353D1v2|Laodelphax striatellus|B: |
| </ | </ | ||
in_vitro_activities.txt · Last modified: by renefeyereisen
